Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Post by LukeCoolHandson Sep 01, 2020 4:12pm
517 Views
Post# 31488449

Steven Brohman CFO of Champignon

Steven Brohman CFO of Champignon  The "old" AND "new" CFO of shrm is Steven Brohman.

  Steven Brohman sold a butt ton of his shrm shares at its peek!

  The "new" address for shrm is suite 605 130 Brew St. Port Moody BC

  This is a condominium. https://bccondos.net/130-brew-st

  It is also the address of "Donaldson Brohman Martin CPA" https://dbmcpa.ca/

 I didn't find Mr. Donaldson but the others are Stephen Brohman & Quinn Martin.

 Mr. Brohman changes the spelling of his first name for some reason.

Stephen Brohman, Quinn Martin, Brian ONeill & others run a company called Adastra Labs https://adastralabs.ca/team/

Adastra is a hyped up about health, marijuana CBD extraction company. 

Brian ONeill is issued 2,050,000 shares of shrm.    https://webfiles.thecse.com/200429_Form_9_Acq_Altmed.pdf?.5Fq54WGbGQhODCvRl6pIMRB350Fg.g3=

Steven/Stephen/Steve Brohman has ALOT of clients that he is CFO for.

I think atleast the shrm shareholders should be concerned that he has way Way WAY too many priorities elsewhere, and just because he lets his condo be shared as Champignon's company headquarters, doesn't mean he should be allowed to run companies poorly. That's not the job of a Company Financial Officer! 

Granted all issues should fall on the CEO's shoulders, however, shrm has chosen a CEO that lives in Toronto, Ontario.

Port Moody, British Columbia is far away from Toronto, Ontario.

It appears the brand new aquisitions in May & April, and health study research tends to occur East near Ontario.

There appears to be some "free time" at shrm with the second halt and all. No word- Not even hopeful speculation about mushroom or psychodelic research or tea sales or "We moved Champignon into a condo". 

Since there's no real operations going on yet- They should move the operation to Ontario before there is.

Doc McIntyre's basement maybe? 

   
<< Previous
Bullboard Posts
Next >>